Fibrinogen beta chain Antibody#54390,Cell Signaling Technology (CST),54390

Fibrinogen beta chain Antibody recognizes endogenous levels of total fibrinogen beta chain protein. This antibody does not cross-react with either fibrinogen Aα or fibrinogen γ proteins.

Reactivity

Human

Application

Western Blotting: 1:1000

Platform ID

BAB476982876

Cell Signaling Technology (CST)

Headquarters

3 Trask Lane Danvers, MA 01923

Contact

Tel: 877-616-2355,978-867-2388
Fax: 877-616-2355

Product Specifications
Scientific Background
Synonyms

Specifications

NameFibrinogen beta chain Antibody#54390
Cat. No.54390
Accession NumberP02675
Gene ID (Entrez)02675, 2244
SensitivityEndogenous
ReactivityHuman
ApplicationWestern Blotting: 1:1000
Molecular Weight55
FormulationSupplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA and 50% glycerol. Store at –20°C.Do not aliquot the antibody.
StorageSupplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA and 50% glycerol. Store at –20°C.Do not aliquot the antibody.
Regulatory StatusResearch Use Only

Scientific Background

Fibrinogen is a large, multimeric plasma glycoprotein that is constitutively synthesized by liver hepatocytes. As a key component of blood clots, fibrinogen plays a central role in hemostasis and thrombosis. In total, six polypeptide chains (2Aα, 2Bβ, and 2γ) are produced intracellularly in a coordinated manner, which are then covalently linked together by a network of disulfide bonds to form a fibrinogen heterohexamer (1). Research studies have shown that expression of the three fibrinogen genes is upregulated as part of the acute phase inflammatory response (2,3).Upon engagement of the clotting cascade, thrombin-mediated cleavage of the fibrinogen Aα and Bβ chains creates fibrin monomers and a platform for the polymerization of fibrin monomers into protofibrils and an insoluble web of stable fibrin fibers (4,5). Whereas thrombin is the enzyme that drives fibrin polymerization and clot formation, plasmin is the enzymatic counterpart that facilitates fibrinolysis and clot breakdown (6).In addition to its position as a central node in the normal coagulation cascade, dysregulated fibrin deposition has been observed in pathological conditions such as cancer and viral infection (7,8).Chapin, J.C. and Hajjar, K.A. (2015)Blood Rev29, 17-24.Dalmon, J. et al. (1993)Mol Cell Biol13, 1183-93.Huber, P. et al. (1990)J Biol Chem265, 5695-701.Lord, S.T. (2011)Arterioscler Thromb Vasc Biol31, 494-9.Yang, Z. et al. (2000)Proc Natl Acad Sci U S A97, 14156-61.Cesarman-Maus, G. and Hajjar, K.A. (2005)Br J Haematol129, 307-21.Fernandez, P.M. et al. (2004)Semin Thromb Hemost30, 31-44.Merad, M. and Martin, J.C. (2020)Nat Rev Immunol20, 355-362.Alternate Namesbeta-fibrinogen; epididymis secretory sperm binding protein Li 78p; FGB; FIBB; Fibrinogen beta chain; fibrinogen, B beta polypeptide; fibrinogen, beta chain; Fibrinopeptide B; HEL-S-78p; MGC104327; MGC120405

Synonyms

beta-fibrinogen; epididymis secretory sperm binding protein Li 78p; FGB; FIBB; Fibrinogen beta chain; fibrinogen, B beta polypeptide; fibrinogen, beta chain; Fibrinopeptide B; HEL-S-78p; MGC104327; MGC120405

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.